Riskpilot← Back to searchSign inGet full accessGenovie AB
ABActiveOrg 5569477598Forskargatan 20 CBusiness and other management consultancy activities · NACE 7020Est. 20130 employees
Revenue 2024
SEK 0
EBITDA margin
—
-59% vs 2023
Equity ratio
0.1%
Financial strength
Net profit 2024
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,1M | -59% |
| Net profit | SEK 0 | — |
| Total assets | SEK 43,8M | +21% |
| Equity | SEK 55K | +0% |
| Employees | 0 | — |
Legal name
Genovie AB
Org number
5569477598
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 november 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med suppleanten Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall direkt eller genom dotterbolag bedriva forskning, utveckling, produktion, marknadsföring och försäljning inom bioteknik samt bedriva annan därmed förenlig verksamhet.
Address
Forskargatan 20 C
Email
ekonomi@anocca.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 287 | −40 | −30 | −32 | −26 | −11 | −22 | −532 | −667 | −1 059 |
| Depreciation & amort. | −83 | −73 | −83 | −83 | −83 | −83 | −83 | −83 | −83 | −83 |
| EBIT | 204 | −113 | −113 | −115 | −109 | −94 | −105 | −615 | −750 | −1 142 |
| Net financials | −258 | −346 | −412 | −502 | — | — | — | — | — | — |
| Profit before tax | −54 | −460 | −525 | −617 | −109 | 0 | −1 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −54 | −460 | −525 | −617 | −109 | 0 | −1 | 0 | 0 | 0 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 681 | 8 621 | 10 669 | 13 593 | 18 076 | 22 340 | 26 295 | 29 960 | 36 222 | 43 793 |
| Equity | 53 | 53 | 53 | 53 | 55 | 55 | 54 | 55 | 55 | 55 |
| Long-term debt | 6 604 | 8 553 | 10 600 | 13 524 | 18 006 | 22 058 | 25 226 | 29 241 | 35 544 | 43 378 |
| Short-term debt | 24 | 15 | 15 | 15 | 15 | 227 | 1 014 | 664 | 623 | 360 |
| Total debt | 6 628 | 8 568 | 10 615 | 13 539 | 18 021 | 22 285 | 26 240 | 29 905 | 36 167 | 43 738 |
EBITDA margin
-105900000.0%
This company
15.8%
Market median
-670253265% vs market
20152024
Equity ratio
0.1%
This company
38.2%
Market median
-100% vs market
20152024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20152024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
795.24×
This company
0.62×
Market median
-128165% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
KA Chief Auditor | Chief Auditor | 2022 | — | — |
JT Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Genovia AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anocca AB
Genovie AB Board members of Genovie AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Reagan Micheal Jarvis | Chief Executive Officer | 0 companies |
| Karl Anders Håkansson | Chief Auditor | 0 companies |
| Jakob Tomas Christoffer Grunditz | Chief Auditor | 0 companies |
| Nils Ragnar Lindqvist | Deputy Board Member | 0 companies |
| Pär Fredrik Roland Hansson | Board of Directors | 0 companies |
| Erik Mikael Blomqvist | Chairman | 0 companies |